Phase Genomics

Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. They offer a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples as well as industry-leading genome and metagenome assembly and analysis software. Founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs, the companys mission is to empower scientists with state-of-the-art genomic tools that will accelerate breakthrough discoveries. The company serves academic and commercial researchers in diverse fields and industries...

Genome assembly,metagenomics,microbiome,bioinformatics,biotech,genomics,scientific discovery,customer satisfaction,hi-c,proximo,proximeta,cancer,chromatin,structural variation,genome,science,science news,ngs,dna,dna sequencing,diagnostic,hi-c kit,human genome,research,scientific research,antibiotic resistance,and plasmids

Phase genomics operates in the Biotechnology research industry.

Phase genomics's revenue is 1m - 10m

Phase genomics has 11 - 50 employees.